A kind of preparation method of 3-o-carbamoylmannose donor derivative, bleomycin disaccharide and its precursor
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- GUANGZHOU UNIVERSITY OF CHINESE MEDICINE
- Publication Date
- 2021-08-10
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicine and chemical industry, and in particular relates to a preparation method of a 3-O-carbamoylmannose donor derivative, bleomycin disaccharide and its precursor. Background technique
[0002] Bleomycin (BLM) is a glycopeptide antitumor antibiotic drug used in the first-line clinical treatment of tumors. It is mainly used to treat squamous cell carcinoma, Hodgkin's malignant lymphoma, cervical cancer and testicular cancer. Streptomyces verticillus. The BLM structure consists of three parts: 1) 5 amino acids composed of pyrimidine-imidazole structure; 2) 1 side chain containing bithiazole amino group; 3) 1 unique disaccharide structure. A large number of studies have shown that the pyrimidine-imidazole structure is the key part of the anti-tumor effect of BLM, which can selectively oxidize and cleave the 5'-GC-3' and 5'-GT-3' sequences in DNA, thereby exerting anti-tumor activity; The structure can ...